
Jonathan Abram Bernstein MD
Professor of Medicine, University Cincinnati
Join to View Full Profile
4665 E Galbraith RdFl 2Cincinnati, OH 45236
Phone+1 513-931-0775
Fax+1 513-931-0779
Dr. Bernstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Bernstein is an allergist/immunologist in Cincinnati, OH and is Professor of Clinical Medicine at the University of Cincinnati College of Medicine Department of Internal Medicine, Division of Internal Medicine Division of Rheumatology, Allergy and Immunology and partner of Bernstein Allergy Grouo and Bernstein Clinical Research Center. He received his medical degree from University of Cincinnati College of Medicine completed his IM residency at the Cleveland Clinic and Allergy fellowship at Northwestern University. He has been in practice 32 years. He is experienced in asthma, rhinitis., hereditary angioedema, mast cell disorders, allergic skin disorders including urticaria, progesterone hypersensitivity and atopic dermatitis and immunodeficiency. He has published over 400 peer reviewed articles and book chapters and is the editor of five books. He is involved in leadership roles in many professional organizations including President elect of the AAAAI.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Allergy and Immunology, 1988 - 1990
Cleveland Clinic FoundationResidency, Internal Medicine, 1985 - 1988
University of Cincinnati College of MedicineClass of 1985
Kenyon CollegeB.A., Chemistry, 1977 - 1981
Certifications & Licensure
OH State Medical License 1986 - 2027
KY State Medical License 2002 - 2026
IN State Medical License 1995 - 2025
IL State Medical License 1988 - 1990
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctor Cincinnati Magazine, 2000-2022
- Distinguished Clinician Award AAAAI, 2019
- Distinguished Clinician Award WAO, 2019
- Join now to see all
Clinical Trials
- Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Start of enrollment: 2006 Nov 01
- Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Start of enrollment: 2010 May 01
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Chronic Urticaria: Current Status and New Therapeutic Perspectives - A Clinical Review.César A Galván, Jonathan A Bernstein
Immunology and Allergy Clinics of North America. 2025-11-01 - Validation of the Symptomatic Dermographism Quality of Life Questionnaire (SD-QoL).Melba Muñoz, Pascale Salameh, Sabine Altrichter, Leslie Durner, Clara Geppert-Steidl
The Journal of Allergy and Clinical Immunology. in Practice. 2025-10-10 - Patient Values and Preferences in Chronic Urticaria Treatment: A Systematic Review.Xiajing Chu, Javeria Mubasher, Lina Chen, Alexandro W L Chu, Paul Oykhman
JAMA Dermatology. 2025-10-08
Journal Articles
- Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema AttacksJonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients with Chronic Idiopathic (Spontaneous) UrticariaJonathan A Bernstein, Michael D Tharp, Ivo Abraham, JAMA
- Correspondence and Reply ReplyJonathan Bernstein, MD, ScienceDirect
- Join now to see all
Books/Book Chapters
Lectures
- 3rd Annual North American Rhinology & Allergy Conference(NARAC)North American Rhinology & Allergy Conference(NARAC), Fajardo, Puerto Rico - 1/31/2013
Other
- Talanta. Portable method of measuring gaseous acetone concentrationsWorrall AD, Bernstein JA, Angelopoulos AP
8/1/2013 - New drug targets and future directions: EcallantideBernstein JA
http://www.futuremedicine.com
1/1/2011 - Allergic Rhinitis and Asthma: Role of Environmental DeterminantsBernstein JA
http://www.consultant.com
7/1/2006 - Join now to see all
Press Mentions
Why a Common Allergy Nasal Spray Might Prevent COVIDSeptember 4th, 2025
Hereditary Angioedema (HAE) Attacks Can Now Be Treated with a PillJuly 16th, 2025
FDA Approval for Hereditary Angioedema Drug a Lifeline for SufferersJune 24th, 2025- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









